Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
medical condition |
| gptkbp:affects |
adipose tissue
|
| gptkbp:associatedWith |
HIV infection
CGL1 CGL2 LMNA gene mutation PPARG gene mutation |
| gptkbp:causedBy |
genetic disorder
antiretroviral therapy autoimmune disease |
| gptkbp:class |
rare disease
|
| gptkbp:complication |
gptkb:liver_disease
gptkb:polycystic_ovary_syndrome pancreatitis cardiomyopathy |
| gptkbp:firstDescribed |
1920s
|
| gptkbp:hasOrphanetID |
ORPHA:199
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lipodystrophy
|
| gptkbp:ICD-10_code |
E88.1
|
| gptkbp:inheritance |
autosomal dominant
autosomal recessive |
| gptkbp:MeSH_ID |
D008070
|
| gptkbp:OMIM |
151660
|
| gptkbp:prevalence |
very rare
|
| gptkbp:riskFactor |
autoimmune disorders
genetic predisposition HIV treatment |
| gptkbp:studiedIn |
genetics
endocrinology metabolism research |
| gptkbp:subspecies |
gptkb:familial_partial_lipodystrophy
gptkb:congenital_generalized_lipodystrophy acquired generalized lipodystrophy acquired partial lipodystrophy |
| gptkbp:symptom |
gptkb:diabetes_mellitus
insulin resistance hypertriglyceridemia hepatic steatosis abnormal fat distribution |
| gptkbp:synonym |
lipoatrophy
fat redistribution syndrome |
| gptkbp:treatment |
gptkb:physician
gptkb:insulin gptkb:metreleptin diet modification lipid-lowering agents |
| gptkbp:bfsParent |
gptkb:DB00005
gptkb:DB00065 |
| gptkbp:bfsLayer |
7
|